menu
    • menu

    Company profile for ATAI Life Sciences

    NEW Drugs in Dev: 12
    ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    Lupin Manufacturing Solutions – delivering high-quality APIs & end-to-end CDMO services for faster, cost-effective drug development.

    Virtual Booth

    Contact Supplier

    Minakem delivers API, HPAPI, steroids & CDMO services for generics with FDA/GMP certification, regulatory know-how & proven success.

    Virtual Booth

    Contact Supplier

    LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-03-23

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    ATAI is a global biotech company builder that leverages a decentralized, technology- and data-driven platform model to serve millions of people suffering with mental health disorders. We are committed to acquiring and efficiently developing innovative treatments that address significant unmet medical needs and lead to paradigm shifts in the mental health space. By pooling expertise, best practices, and resources across our ent...
    ATAI is a global biotech company builder that leverages a decentralized, technology- and data-driven platform model to serve millions of people suffering with mental health disorders. We are committed to acquiring and efficiently developing innovative treatments that address significant unmet medical needs and lead to paradigm shifts in the mental health space. By pooling expertise, best practices, and resources across our entire portfolio, we mitigate risk and responsibly accelerate the development of impactful and evidence-based treatments.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    ATAI Life SciencesGermany Flag
    Country
    Country
    Germany
    Address
    Address
    Barer Straße 7 80333 München
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.atai.life/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/atai-life-sciences/
    youtube
    YouTube
    Twitter
    Twitter
    https://x.com/ATAI_life

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    ICMD China

    ICMD China

    Not Confirmed

    envelop Contact Supplier

    ICMD China

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    AtaiBeckley Joins $3T CRSP Index, S&P Benchmark
    AtaiBeckley Joins $3T CRSP Index, S&P Benchmark

    24 Mar 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/03/24/3261017/0/en/AtaiBeckley-Joins-3-Trillion-CRSP-Index-and-S-P-Benchmark-Indices-Adding-Mandatory-Passive-Fund-Ownership-to-Phase-3-Pipeline-Catalyst.html

    GLOBENEWSWIRE
    24 Mar 2026
    Share Share
    BPL-003 Shows Rapid, Durable Effects in Refractory Depression
    BPL-003 Shows Rapid, Durable Effects in Refractory Depression

    17 Mar 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/03/17/3256934/0/en/BPL-003-Demonstrates-Rapid-and-Durable-Antidepressant-Effects-in-Treatment-Resistant-Depression-Phase-2a-Data-Published-in-Journal-of-Psychopharmacology-Phase-3-Program-on-Track-fo.html

    GLOBENEWSWIRE
    17 Mar 2026
    Share Share
    BPL-003 Phase 3 Program Set for Q2 2026 After FDA Meeting
    BPL-003 Phase 3 Program Set for Q2 2026 After FDA Meeting

    10 Mar 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/03/10/3252558/0/en/BPL-003-Phase-3-Program-Initiation-on-Track-for-Q2-2026-Following-Successful-FDA-End-of-Phase-2-Meeting-AtaiBeckley-Highlights-Key-Pipeline-Milestones-at-2026-Investor-Day.html

    GLOBENEWSWIRE
    10 Mar 2026
    Share Share
    AtaiBeckley Reports FY25 Financial, Business & Clinical Updates
    AtaiBeckley Reports FY25 Financial, Business & Clinical Updates

    06 Mar 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/03/06/3250955/0/en/AtaiBeckley-Reports-Fourth-Quarter-and-Full-Year-2025-Financial-Results-and-Provides-Business-and-Clinical-Update.html

    GLOBENEWSWIRE
    06 Mar 2026
    Share Share
    Ataibeckley Advances BPL-003 For Treatment-Resistant Depression
    Ataibeckley Advances BPL-003 For Treatment-Resistant Depression

    03 Mar 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/03/03/3248186/0/en/AtaiBeckley-Announces-Successful-End-of-Phase-2-Meeting-for-BPL-003-in-Treatment-Resistant-Depression.html

    GLOBENEWSWIRE
    03 Mar 2026
    Share Share
    Ataibeckley's MDMA Drug Improves Anxiety In Ph. 2 Trial
    Ataibeckley's MDMA Drug Improves Anxiety In Ph. 2 Trial

    26 Feb 2026

    // FIERCE BIOTECH

    https://www.fiercebiotech.com/biotech/analysts-high-future-mdma-after-ataibeckleys-positive-top-line-data

    FIERCE BIOTECH
    26 Feb 2026
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search